Entheon Biomedical Corp. (CSE: ENBI)
Canada
· Delayed Price · Currency is CAD 0.135
-0.005 (-3.57%)
Dec 2, 2024, 4:00 PM EST
Entheon Biomedical Company Description
Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. The company is headquartered in Vancouver, Canada.
Entheon Biomedical Corp.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Timothy Ko |
Contact Details
Address: 999 West Broadway Vancouver, V5Z 1K5 Canada | |
| Phone | 604 562 3932 |
| Website | entheonbiomedical.com |
Stock Details
| Ticker Symbol | ENBI |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | December - November |
| Reporting Currency | CAD |
| ISIN Number | CA29383X1033 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Timothy Ko | President, Chief Executive Officer and Director |
| Soo-Whan Kim | Interim Chief Financial Officer |
| Dr. Brian E. Jahns Pharm.D. | Chief Business Officer |
| Kelly Pladson | Corporate Secretary |